This article has been updated from a previous version that incorrectly stated that 7 percent of Qiagen's revenue came from Genaco. The article should have stated that 7 percent of Qiagen's third quarter revenue came from acquisitions.
 
Qiagen officials said this week that the company would seek US Food and Drug Administration clearance next year to market two PCR-based multiplex panels developed by the recently acquired Genaco Biomedical.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.